Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Single-Center, Randomized, Open-Label, Safety and Efficacy Study of Etoposide in Patients With COVID-19 Infection

NCT04356690 is registered in ClinicalTrials.gov with Boston Medical Center as lead sponsor.

NCT NCT04356690
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04356690 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Single-Center, Randomized, Open-Label, Safety and Efficacy Study of Etoposide in Patients With COVID-19 Infection
Lead sponsor
Boston Medical Center
Phase
Phase 2
Overall status
Terminated
Start date
May 8, 2020
Completion date
July 1, 2022
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19